Abstract
Obesity is a major risk factor for cardiovascular disease, the number one killer of Americans. It is also a major risk factor for obstructive sleep apnea, which is rising in the US population as the obesity epidemic continues. Obstructive sleep apnea, in turn, has been implicated as a risk factor for hypertension, glucose dysregulation, and cardiovascular disease. Understanding the pathophysiologic links and the common-soil hypothesis for these rapidly growing disorders is of paramount importance for developing strategic therapeutic and preventive plans. This article discusses the associations of obesity, obstructive sleep apnea, and cardiovascular disease, highlighting the pathophysiologic mechanisms, including increased oxidative stress, endothelial dysfunction, and inflammation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Callow AD: Cardiovascular disease 2005—the global picture. Vascul Pharmacol 2006, 45:302–307.
Murray CJL, Lopez AD: The Global Burden of Disease and Injury Series, vol 1. Cambridge, MA: Harvard University Press; 1996.
American Heart Association: Heart Disease and Stroke Statistics—2007 Update. Dallas, TX: American Heart Association; 2007.
Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary artery disease: the Framingham Study. Ann Intern Med 1971, 74:1–12.
Klein S, Burke LE, Bray GA, et al.: Clinical implications of obesity with specific focus on cardiovascular disease. A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation 2004, 110:2952–2967.
Stampfer MJ, Hu FB, Manson JE, et al.: Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000, 343:16–22.
Hu FB, Stampfer MJ, Manson JE, et al.: Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med 2000, 343:530–537.
Kopelman PG: Obesity as a medical problem. Nature 2000, 404:635–643.
Hedley AA, Ogden CL, Johnson CL, et al.: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 2004, 291:2847–2850.
Wittels EH: Obesity and hormonal factors in sleep and sleep apnea. Med Clin North Am 1985, 69:1265–1280.
Kryger MH: Restrictive lung diseases. In: Principles and Practice of Sleep Medicine, edn 2. Edited by Kryger MH, Roth T, Dement WC. Philadelphia: WB Saunders; 1994:769–775.
Guilleminault C, Tilkian A, Dement WC: The sleep apnea syndrome. Annu Rev Med 1976, 27:465–484.
Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:178–184.
Peker Y, Kraiczi H, Hedner J, et al.: An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999, 14:179–184.
Muller A, Mulhall JP: Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol 2006, 16:435–443.
Messerli FH: Cardiopathy of obesity—a not-so-Victorian disease [editorial]. N Engl J Med 1986, 314:378.
Smith HL, Willius FA: Adiposity of the heart. A clinical and pathologic study of one hundred and thirty-six obese patients. Arch Intern Med 1933, 52:911–931.
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM: The epidemiology of obesity. Gastroenterology 2007, 132:2087–2102.
Metropolitan Life Insurance Company: New weight standards for men and women. Stat Bull Metrop Insur Co 1959, 40:1.
National Institutes of Health: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. Obes Res 1998, 6(Suppl 2):51S–209S.
World Health Organization: The Global Epidemic of Obesity. Geneva: World Health Organization; 1997.
Ogden CL, Carroll MD, Curtin LR, et al.: Prevalence of overweight and obesity in the United States, 1999—2004. JAMA 2006, 295:1549–1555.
Rennie KL, Jebb SA: Prevalence of obesity in Great Britain. Obes Rev 2005, 6:11–12.
Padez C, Fernandes T, Mourao I, et al.: Prevalence of overweight and obesity in 7–9-year-old Portuguese children: trends in body mass index from 1970–2002. Am J Hum Biol 2004, 16:670–678.
Allison DB, Saunders SE: Obesity in North America: an overview. Med Clin North Am 2000, 84:305–330.
Daniels SR, Arnett DK, Eckel RH, et al.: Overweight in children and adolescents. pathophysiology, consequences, prevention, and treatment. Circulation 2005, 111:1999–2012.
Lurbe E, Alvarez V, Redon J: Obesity, body fat distribution, and ambulatory blood pressure in children and adolescents. J Clin Hypertens 2001, 3:362–367.
Lauer RM, Clarke WR: Childhood risk factors for high adult blood pressure: the Muscatine Study. Pediatrics 1989, 84:633–641.
Stevens VJ, Obarzanek E, Cook NR, et al.: Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001, 134:1–11.
El-Atat F, Aneja A, McFarlane S, Sowers J: Obesity and hypertension. Endocrinol Metab Clin North Am 2003, 32:823–854.
Alpert MA, Lambert CR, Panayiotou H, et al.: Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 1995, 76:1194–1197.
Wong CY, O’Moore-Sullivan T, Leano R, et al.: Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol 2006, 47:611–616.
Kip KE, Marroquin OC, Kelley DE, et al.: Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE) Study. Circulation 2004, 109:706–713.
Fantuzzi G, Mazzone T: Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 2007, 27:996–1003.
Shah S, Iqbal M, Karam J, et al.: Oxidative stress, glucose metabolism and the prevention of type 2 diabetes: pathophysiological insights. Antioxid Redox Signal 2007, 9:911–929.
Mahoney LT, Burns TL, Stanford W, et al.: Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol 1996, 27:277–284.
Tauman R, Gozal D: Obesity and obstructive sleep apnea in children. Paediatr Respir Rev 2006, 7:247–259.
Gastaut H, Tassinari CA, Duron B: Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome. Brain Res 1966, 1:167–186.
Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 32:1230–1235.
Gottlieb D, Whitney C, Bonekat W, et al.: Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med 1999, 159:502–507.
Kripke D, Ancoli-Israel S, Kaluber M, et al.: Prevalence of sleep-disordered breathing in ages 40–64 years: a population-based survey. Sleep 1997, 20:65–76.
Neven A, Middlekoop H, Kemp K, et al.: The prevalence of clinically significant sleep apneoa syndrome in the Netherlands. Thorax 1998, 53:638–642.
Carpagnano GE, Kharitonov SA, Resta O, et al.: 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by CPAP therapy. Chest 2003, 124:1386–1392.
Yamauchi M, Nakano H, Maekawa J, et al.: Oxidative stress in obstructive sleep apnea. Chest 2005, 127:1674–1679.
Schultz R, Mahmoudi S, Hattar K, et al: Enhanced release of super oxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000, 162:566–570.
Chin K, Nakamura T, Shimizu K, et al: Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 2000, 109:562–567.
Ip MS, Lam B, Chan LY, et al: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000, 162:2166–2171.
Ip MS, Tse HF, Lam B, et al.: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2003, 169:348–353.
Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al.: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105:2462–2464.
El-Solh AA, Mador MJ, Sikka P, et al.: Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002, 121:1541–1547.
Phillips BG, Narkiewicz K, Pesek CA, et al.: Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999, 17:61–66.
Somers VK, Dyken ME, Clary MP, et al.: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897–1904.
Ip MS, Lam B, Ng MM, et al.: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165:670–676.
Phillips BG, Kato M, Narkiewicz K, et al.: Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000, 279:H234–H237.
Leung RS, Bradley TD: Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 2001, 164:2147–2165.
Shamsuzzaman AS, Gersh BJ, Somers VK: Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003, 290:1906–1914.
Peppard PE, Young T, Palta M, et al.: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342:1378–1384.
Becker HF, Jerrentrup A, Ploch T, et al.: Effect of nasal continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68–73.
Gami AS, Pressman G, Caples SM, et al.: Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110:364–367.
Peker Y, Hedner J, Kraiczi H, et al.: Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000, 162:81–86.
Peker Y, Carlson J, Hedner J: Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006, 28:596–602.
Jung HH, Han H, Lee JH: Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients. Am J Kidney Dis 2005, 45:875–882.
Dyken ME, Somers VK, Yamada T, et al.: Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996, 27:401–407.
Mansfield DR, Gollogly NC, Kaye DM, et al.: Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004, 169:361–366.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iqbal, M., Shah, S., Fernandez, S. et al. Obesity, obstructive sleep apnea, and cardiovascular risk. Curr Cardio Risk Rep 2, 101–106 (2008). https://doi.org/10.1007/s12170-008-0020-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12170-008-0020-5